Warning: The NCBI web site requires JavaScript to function. more...
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies.
Chicheportiche Y, Chicheportiche R, Sizing I, Thompson J, Benjamin CB, Ambrose C, Dayer JM.
Arthritis Res. 2002;4(2):126-33. Epub 2001 Nov 9.
Related citations
Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
Burger D, Rezzonico R, Li JM, Modoux C, Pierce RA, Welgus HG, Dayer JM.
Arthritis Rheum. 1998 Oct;41(10):1748-59.
Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
Alsalameh S, Amin RJ, Kunisch E, Jasin HE, Kinne RW.
J Rheumatol. 2003 Aug;30(8):1680-90.
Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts.
Ahmed S, Pakozdi A, Koch AE.
Arthritis Rheum. 2006 Aug;54(8):2393-401.
Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S.
Arthritis Rheum. 2003 Mar;48(3):642-50.
CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.
García-Vicuña R, Gómez-Gaviro MV, Domínguez-Luis MJ, Pec MK, González-Alvaro I, Alvaro-Gracia JM, Díaz-González F.
Arthritis Rheum. 2004 Dec;50(12):3866-77.
The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes.
Burger D, Begué-Pastor N, Benavent S, Gruaz L, Kaufmann MT, Chicheportiche R, Dayer JM.
Rheumatology (Oxford). 2003 Jan;42(1):89-96.
Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C.
J Immunol. 2006 Feb 1;176(3):1889-98.
Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H, He Y, Yang X, Liang L, Zhan Z, Ye Y, Yang X, Lian F, Sun L.
Rheumatology (Oxford). 2007 Jun;46(6):920-6. Epub 2007 Feb 21.
Cordycepin inhibits IL-1beta-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts.
Noh EM, Kim JS, Hur H, Park BH, Song EK, Han MK, Kwon KB, Yoo WH, Shim IK, Lee SJ, Youn HJ, Lee YR.
Rheumatology (Oxford). 2009 Jan;48(1):45-8.
Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Kamijo S, Nakajima A, Kamata K, Kurosawa H, Yagita H, Okumura K.
Rheumatology (Oxford). 2008 Apr;47(4):442-50. Epub 2008 Feb 29.
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N.
Arthritis Rheum. 2003 Jun;48(6):1521-9.
Anti-inflammatory effect of linear polarized infrared irradiation on interleukin-1beta-induced chemokine production in MH7A rheumatoid synovial cells.
Shibata Y, Ogura N, Yamashiro K, Takashiba S, Kondoh T, Miyazawa K, Matsui M, Abiko Y.
Lasers Med Sci. 2005 Dec;20(3-4):109-13. Epub 2005 Jul 27.
Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines.
Shimizu M, Yasuda T, Nakagawa T, Yamashita E, Julovi SM, Hiramitsu T, Nakamura T.
J Rheumatol. 2003 Jun;30(6):1164-72.
Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, Akiyoshi M, Yoshida M, Nakamura T.
Rheumatology (Oxford). 2006 Jul;45(7):824-32. Epub 2006 Jan 31.
Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
Kim KS, Oh da H, Choi HM, Bang JS, Ryu CJ, Kim JH, Yoo MC, Yang HI.
Eur J Pharmacol. 2009 Jun 24;613(1-3):167-75. Epub 2009 Apr 18.
Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M, Hara M, Kawamoto M, Kawaguchi Y, Sugiura T, Tanaka M, Nakagawa M, Ichida H, Takagi K, Higami-Ohsako S, Shimada K, Kamatani N.
Arthritis Rheum. 2004 Jul;50(7):2167-77.
Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals.
Cheon H, Yu SJ, Yoo DH, Chae IJ, Song GG, Sohn J.
Clin Exp Immunol. 2002 Mar;127(3):547-52.
Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts.
Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujiyama M, Bamba T.
Scand J Gastroenterol. 2002 Mar;37(3):317-24.
[Effects of TWEAK on the synthesis of MMP-3 in fibroblast-like synoviocytes of rheumatoid arthritis].
Xia LP, Xiao WG, Li JS, Ding S, Lu J.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Jan;25(1):46-8. Chinese.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on